nerlynxhcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Sitemap: https://nerlynxhcp.com/sitemap/sitemap-index.xml | ||
Meta Tags
| Title | For healthcare professionals │ NERLYNX® (neratinib) |
| Description | You may have patients like NERLYNX is indicated for the treatment of early-stage and metastatic HER2+ breast cancer. See recurrence and progression rates |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 40.82.255.130 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
nerlynxhcp.com Valuation
|
US$5,968,456
Last updated: 2023-05-16 12:43:14
nerlynxhcp.com has Semrush global rank of 1,773,374. nerlynxhcp.com has an estimated worth of US$ 5,968,456, based on its estimated Ads revenue. nerlynxhcp.com receives approximately 688,668 unique visitors each day. Its web server is located in United States, with IP address 40.82.255.130. According to SiteAdvisor, nerlynxhcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$5,968,456 |
| Daily Ads Revenue | US$5,510 |
| Monthly Ads Revenue | US$165,281 |
| Yearly Ads Revenue | US$1,983,364 |
| Daily Unique Visitors | 45,912 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| nerlynxhcp.com. | A | 600 | IP: 40.82.255.130 |
| nerlynxhcp.com. | NS | 3600 | NS Record: ns26.domaincontrol.com. |
| nerlynxhcp.com. | NS | 3600 | NS Record: ns25.domaincontrol.com. |
HtmlToTextCheckTime:2023-05-16 12:43:14
| Indications: Nerlynx ® (neratinib) tablets, for oral use, is a kinase inhibitor indicated: As a single agent, for the extended adjuvant treatment of adult patients with early-stage HER2-positive breast cancer, to follow adjuvant trastuzumab-based therapy. Read More In combination with capecitabine, for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 based regimens in the metastatic setting. For Patients Indications Important Safety Information Prescribing Information Risk of Recurrence Early-Stage Breast Cancer Metastatic Breast Cancer Clinical Guidelines Mechanism of Action Access and Support Resources You may have patients like Mary She’s worked hard to get this far Acting with urgency can help give patients with HER2+ eBC the chance to live disease free 1 Review the risk of recurrence Real patient with HER2+ HR+ breast cancer who had a pCR. NERLYNX was not commercially available at the time of |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 0 Content-Type: text/html; charset=UTF-8 Location: https://nerlynxhcp.com/ Date: Wed, 26 Jan 2022 11:52:51 GMT HTTP/1.1 200 OK Cache-Control: public, max-age=0 Content-Length: 87066 Content-Type: text/html; charset=UTF-8 Last-Modified: Mon, 18 Oct 2021 17:18:40 GMT Accept-Ranges: bytes ETag: W/"1541a-17c94699580" X-Powered-By: Express Date: Wed, 26 Jan 2022 11:52:51 GMT |
nerlynxhcp.com Whois Information
Domain Name: NERLYNXHCP.COM Registry Domain ID: 2576270996_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-12-04T14:20:07Z Creation Date: 2020-12-03T17:07:06Z Registry Expiry Date: 2022-12-03T17:07:06Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS25.DOMAINCONTROL.COM Name Server: NS26.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-01-26T08:13:11Z <<< |